Any nay-sayers at this point is just noiseEveryone at some point has doubts or questions a companies leadership. This is not one of those times for Aphria or Tilray. Tilray elminated almost the entirety of its reported looses last quarter as it moves for massive efficiency and will soon utilize aphrias state of the art facilities which can drastically reduce the cost per gram which was tilrays only weakness as far as I can see. With every aforementioned fact I said in previous posts plus CBD coming in the USA with some clarification from The USA feds things are just heading in the right direction. It can't be denied